These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3444162)

  • 1. [Effects of diethylstilbestrol diphosphate (DES-P) and alpha-interferon on natural killer cell activity in vitro].
    Ueno M; Marumo K; Muraki J; Baba S; Murai M; Tazaki H; Yamamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1707-16. PubMed ID: 3444162
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the cytotoxic activity of diethylstilbestrol and its mono- and diphosphate towards prostatic carcinoma cells.
    Schulz P; Bauer HW; Brade WP; Keller A; Fittler F
    Cancer Res; 1988 May; 48(10):2867-70. PubMed ID: 2834049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
    Kalland T; Haukaas S
    Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of diethylstilboestrol and the LHRH analogue leuprolide on natural killer cell activity.
    Ablin RJ; Bartkus JM; Gonder MJ
    Immunopharmacology; 1988; 15(2):95-101. PubMed ID: 2453486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic agents and modulation of natural killer cell activity in vitro.
    Charamella LJ; Meyer C; Thompson GE; Dimitrov NV
    J Immunopharmacol; 1985; 7(1):53-65. PubMed ID: 4008941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the mitochondrial bc1-complex in the cytotoxic action of diethylstilbestrol-diphosphate toward prostatic carcinoma cells.
    Schulz P; Link TA; Chaudhuri L; Fittler F
    Cancer Res; 1990 Aug; 50(16):5008-12. PubMed ID: 2165852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity and metabolism of E-DES-diphosphate.
    Oelschläger H; Rothley D; Dunzendorfer U
    Prog Clin Biol Res; 1989; 303():187-95. PubMed ID: 2780647
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of in vivo diethylstilbosterol phosphate on some human blood lymphocyte sub-populations.
    Onsrud M; Sander S
    Acta Pathol Microbiol Immunol Scand C; 1982 Oct; 90(5):271-6. PubMed ID: 6217720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay of diethylstilbestrol in plasma of patients with prostatic carcinoma.
    Usui T; Nakamura K; Osumi T; Ishibe T; Kitano T; Kambegawa A; Miyachi Y
    Arch Androl; 1984; 12(2-3):243-9. PubMed ID: 6508431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diethylstilbestrol-diphosphate-induced disseminated intravascular coagulation in prostatic carcinoma.
    Cornfield DB; Rossman RE
    South Med J; 1982 Feb; 75(2):248-9. PubMed ID: 7058376
    [No Abstract]   [Full Text] [Related]  

  • 11. [High-dose intravenous diethylstilbestrol diphosphate therapy for hormone refractory prostate cancer].
    Honda M; Umeda H; Yoshida K
    Nihon Rinsho; 1998 Aug; 56(8):2145-9. PubMed ID: 9750524
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells.
    Robertson CN; Roberson KM; Padilla GM; O'Brien ET; Cook JM; Kim CS; Fine RL
    J Natl Cancer Inst; 1996 Jul; 88(13):908-17. PubMed ID: 8656443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in natural killer activity in peripheral blood during the menstrual cycle.
    McDonald FG; Ferguson MM
    Br Med J (Clin Res Ed); 1985 May; 290(6480):1514-5. PubMed ID: 3922554
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of prostate cancer with a large abdominal mass effectively treated with a high dose of diethylstilbestrol-diphosphate.
    Wakisaka M; Takagishi H
    Hinyokika Kiyo; 1993 Sep; 39(9):849-51. PubMed ID: 8213382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma.
    Russo P; Liguori G; Heston WD; Huryk R; Yang CR; Fair WR; Whitmore WF; Herr HW
    Cancer Res; 1987 Nov; 47(22):5967-70. PubMed ID: 3664500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estrogen therapy--high-dose intravenous diethylstilbestrol diphosphate therapy for advanced or hormone refractory prostate cancer].
    Nakagawa M
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():199-204. PubMed ID: 12599571
    [No Abstract]   [Full Text] [Related]  

  • 17. A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer.
    Citrin DL; Kies MS; Wallemark CB; Khandekar J; Kaplan E; Camacho F; Lind R
    Cancer; 1985 Aug; 56(3):457-60. PubMed ID: 4005808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate.
    Susan LP; Roth RB; Adkins WC
    Urology; 1976 Jun; 7(6):598-601. PubMed ID: 936380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer. Possible implications.
    Citrin DL; Elson P; Kies MS; Lind R
    Am J Med; 1984 May; 76(5):787-93. PubMed ID: 6539069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability, distribution and pharmacokinetics of diethylstilbestrol converted from diethylstilbestrol diphosphate in patients with prostatic cancer.
    Nakamura K
    Hiroshima J Med Sci; 1986 Dec; 35(4):325-38. PubMed ID: 3570844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.